Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug market, according to a new report published today by the EU Drugs Agency (EUDA). The study, Ketamine in Europe, provides the first comprehensive multi-country intelligence picture of how organised criminal networks are exploiting legitimate pharmaceutical supply chains in Europe and the implications this may have for public health and law enforcement. The report was produced within the framework of the European Multidisciplinary Platform Against Criminal Threats (EMPACT…
Read more
Why is it important to consider a gender perspective in the drugs field? What do the data tell us about the main gender differences in drug use and drug-related harms in Europe? Is the gender gap in drug use narrowing among younger generations? How can gender-responsive interventions be implemented in the drugs field?
These are just some of the questions posed in our Frequently asked questions (FAQ): gender and drugs in Europe published today.
The new resource provides answers to important questions on gender and drugs, with a particular focus on the European situation…
Read more
On World Energy Efficiency Day, we are delighted to announce that the EUDA has been officially registered under the EU Eco-Management and Audit Scheme (EMAS), in recognition of its commitment to reducing its environmental impact.
EMAS is the EU voluntary instrument for environmental management and auditing, which allows organisations to evaluate, report on, and continuously improve their environmental performance. Registration is valid for three years and can be renewed following a successful reassessment.
Environmental management has been an integral part of our operations for over a…
Read more
